Public Employees Retirement System of Ohio Decreases Stake in Humana Inc. (NYSE:HUM)

Public Employees Retirement System of Ohio cut its position in shares of Humana Inc. (NYSE:HUM) by 4.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 51,521 shares of the insurance provider’s stock after selling 2,508 shares during the period. Public Employees Retirement System of Ohio’s holdings in Humana were worth $16,319,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of HUM. Creative Financial Designs Inc. ADV increased its position in shares of Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 61 shares during the last quarter. CarsonAllaria Wealth Management Ltd. increased its position in shares of Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after acquiring an additional 39 shares during the last quarter. Atwood & Palmer Inc. acquired a new stake in shares of Humana during the third quarter valued at about $29,000. Ashton Thomas Securities LLC acquired a new stake in shares of Humana during the third quarter valued at about $31,000. Finally, Your Advocates Ltd. LLP increased its position in shares of Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after acquiring an additional 45 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Down 0.1 %

HUM stock opened at $285.82 on Wednesday. The company has a fifty day moving average price of $272.07 and a 200 day moving average price of $326.37. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $488.89. The company has a market cap of $34.42 billion, a price-to-earnings ratio of 25.32, a price-to-earnings-growth ratio of 2.18 and a beta of 0.53. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Sell-side analysts expect that Humana Inc. will post 16.14 earnings per share for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.24%. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Analysts Set New Price Targets

A number of research analysts recently weighed in on HUM shares. Leerink Partners cut shares of Humana from an “outperform” rating to a “market perform” rating and dropped their price objective for the company from $400.00 to $250.00 in a report on Wednesday, October 2nd. JPMorgan Chase & Co. lifted their price objective on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. Bank of America upgraded shares of Humana from an “underperform” rating to a “neutral” rating and lifted their price objective for the company from $247.00 to $308.00 in a report on Wednesday, November 6th. Cantor Fitzgerald reiterated a “neutral” rating and set a $395.00 price target on shares of Humana in a report on Tuesday, October 1st. Finally, Jefferies Financial Group cut shares of Humana from a “buy” rating to a “hold” rating and lowered their price target for the stock from $519.00 to $253.00 in a report on Monday, October 7th. Twenty equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $315.86.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.